Special items: Ovarian Cancer and Us blog best viewed in Firefox

Thursday, January 21, 2010

Jan 2009 full free access - Development of PARP inhibitors in oncology; Expert Opinion on Investigational Drugs + Expert Opinion

Note: highly technical but worth reviewing (BRCAness, sporadic, specific therapies (combination/single agent/+radiotherapy), those in clinical studies (Table 1),
differing cancers etc

No comments:

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.